Perioperative Use of Intravenous Levodopa as an Anti-Parkinsonian Drug: A Propensity Score Analysis.

Satoshi KodamaTaisuke JoHideo YasunagaHiroyuki OhbeNobuaki MichihataHiroki MatsuiAkira OkadaYuichiro ShirotaKiyohide FushimiTatsushi TodaMasashi Hamada

Published in: Movement disorders clinical practice (2023)

Intravenous levodopa was associated with a shorter postoperative length of stay, but not with mortality or morbidity. Intravenous levodopa may improve perioperative care in patients with Parkinson's disease.

Keyphrases

parkinson disease
patients undergoing
deep brain stimulation
high dose
cardiac surgery
healthcare
palliative care
acute kidney injury
risk factors
low dose
emergency department
type diabetes
pain management
quality improvement
coronary artery disease
health insurance